Olaris Therapeutics

Olaris Therapeutics is a precision medicine company founded in 2014 that leverages metabolomics and machine learning to develop in vitro diagnostics. Its core mission is to identify Biomarkers of Response (BoRs) to determine which patients will benefit from a specific therapy, thereby optimizing outcomes and reducing adverse events. The company aims to remove the guesswork from medicine by getting the right drug to the right patient at the right time.